Works by Zang, Dae


Results: 87
    1
    2
    3
    4
    5
    6

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 2, p. 341, doi. 10.3109/10428194.2015.1049166
    By:
    • Park, Joon Seong;
    • Lee, Sung-Eun;
    • Jeong, Seong Hyun;
    • Jang, Eun-Jung;
    • Choi, Mi-Yeon;
    • Kim, Hyeoung-Joon;
    • Kim, Yeo-Kyeoung;
    • Kim, Sung-Hyun;
    • Zang, Dae Young;
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kim, Hawk;
    • Do, Young Rok;
    • Kwak, Jae-Yong;
    • Kim, Jeong-A;
    • Kim, Dae-Young;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Chang, Myung Hee;
    • Park, Jinny
    Publication type:
    Article
    21

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    22
    23
    24
    25
    26

    Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 6, p. 449, doi. 10.1002/ajh.23427
    By:
    • Lee, Sung-Eun;
    • Choi, Soo Young;
    • Bang, Ju-Hee;
    • Kim, Soo-Hyun;
    • Jang, Eun-jung;
    • Byeun, Ji-Young;
    • Park, Jin-Eok;
    • Jeon, Hye-Rim;
    • Oh, Yun Jeong;
    • Kim, Hyeoung-Joon;
    • Kim, Yeo-Kyeoung;
    • Park, Joon Seong;
    • Jeong, Seong Hyun;
    • Kim, Sung-Hyun;
    • Zang, Dae Young;
    • Oh, Sukjoong;
    • Koo, Dong Hoe;
    • Kim, Hawk;
    • Do, Young Rok;
    • Kwak, Jae-Yong
    Publication type:
    Article
    27
    28
    29

    Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S17, doi. 10.1016/j.clml.2017.09.045
    By:
    • Hee-Je Kim;
    • Hea-Lyun Yoo;
    • Won-Sik Lee;
    • Hyeong-Joon Kim;
    • Jee Hyun Kong;
    • Yunsuk Choi;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Sukjoong Oh;
    • Sung Hyun Kim;
    • Jeong-A. Kim;
    • Dae Young Zang;
    • Yeung-Chul Mun;
    • Young-Woong Won;
    • Sung-Eun Lee;
    • Dong-Wook Kim
    Publication type:
    Article
    30

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12338-y
    By:
    • Kim, Sun Young;
    • Kim, Jee Hyun;
    • Kim, Tae-Yong;
    • Park, Sook Ryun;
    • Yoon, Shinkyo;
    • Lee, Soohyeon;
    • Lee, Se-Hoon;
    • Kim, Tae Min;
    • Han, Sae-Won;
    • Kim, Hye Ryun;
    • Yun, Hongseok;
    • Lee, Sejoon;
    • Kim, Jihun;
    • Choi, Yoon-La;
    • Choi, Kui Son;
    • Chae, Heejung;
    • Ryu, Hyewon;
    • Lee, Gyeong-Won;
    • Zang, Dae Young;
    • Ahn, Joong Bae
    Publication type:
    Article
    38
    39
    40

    Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
    By:
    • Jung, Minkyu;
    • Ryu, Min-Hee;
    • Oh, Do Youn;
    • Kang, Myounghee;
    • Zang, Dae Young;
    • Hwang, In Gyu;
    • Lee, Keun-Wook;
    • Kim, Ki Hyang;
    • Shim, Byoung Yong;
    • Song, Eun Kee;
    • Sym, Sun Jin;
    • Han, Hye Sook;
    • Park, Young Lee;
    • Kim, Jin Soo;
    • Lee, Hyun Woo;
    • Lee, Moon Hee;
    • Koo, Dong-Hoe;
    • Song, Hong Suk;
    • Lee, Namsu;
    • Yang, Sung Hyun
    Publication type:
    Article
    41

    Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 802, doi. 10.1007/s10120-018-0794-1
    By:
    • Kim, Hyeong Su;
    • Ryu, Min-Hee;
    • Zang, Dae Young;
    • Park, Sook Ryun;
    • Han, Boram;
    • Kang, Won Ki;
    • Rha, Sun Young;
    • Jung, Minkyu;
    • Kim, Jin-Soo;
    • Kang, Byung Woog;
    • Lee, Kyung-Hee;
    • Rho, Sang-Young;
    • Kim, Jung Han;
    • Kim, Kab Choong;
    • Cho, Ji Woong;
    • Choi, Dae Ro;
    • Lim, Hyun;
    • Kang, Ho Suk;
    • Soh, Jae Seung;
    • Kim, Min-Jeong
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50